Palladyne AI Corp. 8-K Report: Future Insights on Common Stock & Redeemable Warrants

$PDYN
Form 8-K
Filed on: 2025-02-20
Source
Palladyne AI Corp. 8-K Report: Future Insights on Common Stock & Redeemable Warrants

Based on the provided section of the financial report, here are the key pieces of information extracted:

  1. Entity Information:
  • Company Name: Palladyne AI Corp.
  • CIK: 0001826681
  • SEC File Number: 001-39897
  • EIN: 85-2838301
  • Address: 650 South 500 West, Suite 150, Salt Lake City, UT 84101
  • Contact Number: (888) 927-7296
  1. Report Type:
  • Form: 8-K (a report of unscheduled material events or corporate changes)
  1. Stock Information:
  • Common Stock:
    • Par Value: $0.0001 per share
    • Ticker Symbol: PDYN
    • Exchange: NASDAQ
  • Redeemable Warrants:
    • Ticker Symbol: PDYNW
    • Exercise Price: $69.00 per share
    • These warrants are exercisable for shares of Common Stock.
  1. Reporting Dates:
  • Report Period Start Date: February 20, 2025
  • Report Period End Date: February 20, 2025
  1. Stock Classifications:
  • The report indicates two classifications of stock:
    • Common Stock
    • Redeemable Warrants
  1. XBRL Contexts:
  • The report includes different contexts identifying the type of stock being reported (Common Stock and Redeemable Warrants).

Insights:

  • The report is part of a standard SEC filing procedure (8-K), indicating that Palladyne AI Corp. may have undergone a significant event or change that necessitates reporting.
  • The exercise price of the redeemable warrants at $69.00 suggests a potentially high value given current market conditions, as investors will compare this price against the market price of the common stock (PDYN).
  • The report is filed with a future date (February 20, 2025), which may imply either a forward-looking statement or anticipation of a specific event.

Overall, the report suggests that Palladyne AI Corp. is actively involved in capital raising or financial restructuring activities, given the mention of redeemable warrants alongside common stock.